alexa Congenital Heart Disease And Impact On Child Development
ISSN: 2329-6607

Cardiovascular Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

11th World Congress on Pediatric Cardiology and Congenital Cardiovascular Disease
April 18-19, 2017 London, UK

Veronique Diane and Noah Mvongo
University of Douala, Cameroon
ScientificTracks Abstracts: Cardiovasc Pharm
DOI: 10.4172/2329-6607-C1-002
Objectives: To evaluate the child development and evaluate a possible association with the commitment by bio-psychosocial factors of children with congenital heart disease and those without the infection. Methods: This research is an observational case-control study comparing the development of children with and without heart disease, categorized in three groups. Group 1(G1): children 0-10years of age both male and female genders with congenital heart disease awaiting surgery; Group 2 (G2): children of age 0-10years of both genders who have undergone at least one surgical procedure for congenital heart disease correction between 6 months and 1 year before the application of the instruments of this study; Group 3 (G3): Children 0-10 years, healthy and both genders. As instruments, we used a bio- psychosocial data questionnaire that includes social, demographic, psychological and clinical factors, and a development screen test divided into four fields of functions i.e. personalsocial, fine-motor-adaptive, language and gross motor. Results: Ninety six children were evaluated, 19 (22.66%) belonging to the G1 (preoperative children with heart disease), 32 (33.59%) in Group 2 (postoperative children with heart disease) and 45 (43.75%) in G3 (healthy children). Of the total, 55.56% are girls and age ranged from 2 months to 10 years. The children with heart disease had more suspicious and abnormal ratings and in the group of healthy children 53.6% were considered with normal development (P≤0.0001). The biopsychosocial variables that were related to a possible developmental delay were gender (P=0.042), child's age (P=0.001) and income per capita (P=0.019). Conclusion: The results suggest that children with congenital heart disease are likely to have a developmental delay with significant difference between children who have undergone surgery and those awaiting surgery under clinical follow-up.

Veronique Diane has completed her Doctor of Medicine degree from the Faculty of Medicine and Pharmaceutical Sciences, University of Douala. She is currently working as a General Medical Practitioner at the Limber Regional Hospital in Limbe, Cameroon. She intends to be a Cardiac Specialist in the future and has been researching on Cardiac Medicines both at the University of Douala and at the Cardiac Centre of St. Elizabeth Catholic General Hospital Shisong, Cameroon.

Email: [email protected]

image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version